Ken Chahine, founder and CEO at Nectar Life Sciences on your radar. Ken has a fascinating story: a child of immigrant parents, neither of whom finished elementary school, he earned a PhD in Biochemistry (U of Michigan) and a JD in patent law. 

After transforming the field of genetic testing for genealogy as General Manager of Ancestry DNA, he founded Nectar, a health tech company revolutionizing the allergy space with at-home allergy testing and treatment with sublingual drops.
In grad school, Ken suffered from severe allergies that made lab work in goggles near-impossible. When he discovered the healthcare system’s solution for chronic allergy sufferers is constant medications (average = 3 meds per day) and/or painful, inconvenient shots, he knew there had to be a better way.
Just a sample of what Ken can elaborate on:
First-hand experience with allergies as a chronic condition and advocating for the consumer 
Long-term benefits of at-home allergy testing + treatment
Why sublingual (under the tongue) treatment is already standard in Europe as a safer alternative to subcutaneous (shots)
How he transitioned into the allergy space after revolutionizing the genetic science behind Ancestry.com
Predictions for holistic approaches in the healthcare space

Ver todos los episodios